Since VEGF-C enhances the VEGF-A action [11], prevention of VEGF-C secretion should be considered in designing new therapies for diabetic retinopathy, or in potentiating the currently available experimental anti-VEGF-A treatment [35]. This evidence concerns the gene VEGFA and diabetic retinopathy.